Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | 2-Methylpiperidine | HCID 7974 | — |
| Reactant | Isobutyl chloroformate | HCID 62365 | — |
| Reactant | L-isoleucine, N-[1-(carboxymethyl)-L-prolyl] benzylamide | HCID 131720284 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | L-Isoleucine | HCID 6306 | 115.1% |
Reaction Steps
A -5° C. solution of L-isoleucine, N-[1-(carboxymethyl)-L-prolyl] benzylamide (202 mg, 0.53 mmol, 1.0 eq), N-ethylmorpholine (82 uL, 0.64 mmol, 1.20 eq) in acetonitrile (8 mL) was treated with isobutyl chloroformate (80 uL, 0.62 mmol, 1.15 eq) followed by 2-methylpiperidine (0.106 g, 1.07 mmol, 2.0 eq). The solution was warmed to 22° C., concentrated to a residue, and purified by flash chromatography to provide 80 mg (32%) of L-isoleucine, N-[1-[2-(N-(2-methylpiperidine))-2-oxoethyl]-L-prolyl] benzylamide as a colorless oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05686424 |
|---|
| Source dataset | uspto-grants-1997_11 |
|---|
| ORD ID | ord-191246fddc3e49438f3f690b4a7735a8 |
|---|
| Source note | uspto-grants-1997_11 |
|---|